chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My adverse reaction was with my second dose. There was none with the first dose. My arm was sore, itchy, and red.  The soreness, redness, itchiness increased and some swelling at the point where I got the shot. That lasted about 2 days.
Woke the next morning after 2nd shot to ulnar nerve in both arms numb or "asleep".  Sent for nerve tests, which was described as Diabetic Neuropathy. I didn't agree because it was sudden onset.  I had cubital tunnel release surgery on both elbows. No change in numbers.  I had the booster, 3rd shot, on Oct 2. Within a few hours  both ulnar nerves were twitching constantly.  It in lasted about 12 hours.  That's why I'm reporting.  I am more sure than ever, the numbness resulted from the vaccine.
Breakthrough case 10 months after vaccination. Husband tested positive for COVID-19 and I tested myself and was positive for COVID-19 as well. Had sore throat and congestion. Have had Bronchitis in the past, so thought my symptoms were related to that. Started feeling better after about 10 days after. Didn't feel the need to re-test and is doing better. When I got COVID-19 it seemed to cure my chronic Bronchitis, because it seemed to make my immune system stronger.
Flu-like sx-achey all over w/moderate joint pain in both knees; H/A, chills productive cough & nasal congestion; Tx Amoxicillin, Phrenilin Forte & Nolex LA;
Varicella vaccine was administered after reconstitution with 0.9% NaCl instead of sterile water.  The vaccine was given SQ, without abnormal reaction or symptoms. Patient's guardian was notified of the error, asked to monitor for adverse reactions, and patient was continuously monitored throughout the 15 min post-vaccine period.
pt recv vax 2FEB96 & exp generalized itching which turned red;MD office called it a systemic cutaneous rxn;skin testing was negative & pt refused further vax w/hepatitis vax;
No adverse event; Patient received a dose of VARIVAX and wanted a shingles vaccine; This spontaneous report was received from a registered pharmacist referring to a 67 year old patient of unspecified gender.  No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.    On 05-APR-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported), but the patient wanted a shingles vaccine.  The reporter stated that they were overwhelmed with Covid vaccines that she did not catch the error before.  No additional adverse events or product quality complaints were reported.
Information has received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided.  On 25-SEP-2016, the patient was vaccinated with improperly stored  VARIVAX subcutaneous injection (lot # M012990, expiration date 14-MAR-2018, 0.5 ml, once, subcutaneously) for prophylaxis. On 25-DEC-2016, the vaccine was exposed to 28 Fahrenheit degree for 2 hours and 10 minutes. No adverse effects were reported. Data logger was involved. There was no prior excursion. On 06-DEC-2016, the registered nurse provided contact details to contact other nurse who could provide additional information about the patient. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1610USA009079: US-009507513-1610USA009080: US-009507513-1610USA009085: US-009507513-1610USA001984: US-009507513-1610USA009083: US-009507513-1610USA009084: US-009507513-1610USA009078: US-009507513-1610USA009081:, MERCK 1610USA009082:Mfr number.
Allergies developed to all dairy, seafood, nuts, beef, dust, pollen. 2022 has been my worst year ever with pollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03May2021 at 17:00 as dose 2, single (Lot number: Er8734) at the age of 47 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Pollen" (unspecified if ongoing); "Beef" (unspecified if ongoing); "Seafood" (unspecified if ongoing); "nuts beef" (unspecified if ongoing); "All-mycin" (unspecified if ongoing); "Dairy" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, lot number: Er8737, administration date: 05Apr2021, administration time: 02:00 PM, vaccine location: Right arm), administration date: 05Apr2021, for COVID-19 immunization. The following information was reported: FOOD ALLERGY (disability) with onset 04Aug2021 at 13:00, outcome "not recovered", described as "Allergies developed to all dairy, seafood, nuts, beef, dust, pollen. 2022 has been my worst year ever with pollen". Therapeutic measures were taken as a result of food allergy.  Clinical course: Allergies developed to all dairy, seafood, nuts, beef, dust, pollen. 2022 has been my worst year ever with pollen. AE treatment: All allergy remedies but non-works. AE resulted in: Doctor or other healthcare professional office/clinic visit, Disability or permanent damage. Patient had Known allergies: Pollen, beef, diary, seafood, nuts beef, all-mycin prescribed medicine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Any other medications within two weeks: No. Prior to vaccination, the patient was not diagnosed with COVID-19. Covid tested post vaccination: Yes.   Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200875058 similar report from same reporter;
Viral like Symptoms; Rash on both of my calves, back side of the legs; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Viral like Symptoms) and RASH (Rash on both of my calves, back side of the legs) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0391A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Viral like Symptoms) and RASH (Rash on both of my calves, back side of the legs). On 30-Mar-2021, INFLUENZA LIKE ILLNESS (Viral like Symptoms) had resolved. At the time of the report, RASH (Rash on both of my calves, back side of the legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
On 2/17/22 patient was administered vaccine that expired on 2/12/22.
approx 5 days p/HIB/DTP/MMR pt exp an urticarial rash @ the HIBTITER inject site which lasted approx 2 days;
I received the Moderna vaccine. I developed symptoms of Bells Palsy about 4 hours after the vaccination.
Information has been received from a female consumer with no medical history or allergies who in 1997 was vaccinated with three 1.0 ml dose series of Recombivax HB.  Hepatitis antibody titer in 1997 was positive.  There was no concomitant medication.  In 1997 the patient experienced muscle soreness at injection site for "a day or so".  In December 2006, the patient had anti hepatitis antibody negative.  At the time of report, the patient did not recover.  Unspecified medical attention was sought.  Laboratory diagnostic test of serum hepatitis B surface antibody screen was undertaken in December 2006.  A product quality complaint was not involved.  Additional information has been requested.
I received a tetanus vaccine in the ED due to a minor cut on my finger. Within 2 days, the following occured Extreme shoulder pain, extreme limitation for range of motion; could not raise arm/elbow to about 1/3 of normal range. Aching/sharp pains. Pain made worse w/abduction motions. Pain often interferes w/sleep. Given Prednisone, 12 day course After round of prednisone was complete; pain, stiffness, and lack of mobility recurred. Dates of Treatment: 08/30/22 - Orthopaedics -> Initial Visit 09/19/22 - Orthopaedics -> Return for continued pain 09/23/22 - Neurology as recommended for possible nerve damage 09/27/22, 10/17/22, 11/10/22 - Physical Therapy Appointments 10/18/22 - Neurology Procedure - EMG testing On the evening of 8/21/22 I was in the ED for approx. 4 hours to receive 2 stitches from a laceration. The dept. was extremely busy and understaffed (I believe 1 doctor, 1 nurse and a few medical assistants). I was told that another Hospital that evening was better staffed and had a far less wait time. After being treated for the laceration, I was given a tetanus shot. The shot was not given in the deltoid muscle, but at the upper part of the shoulder, was told at my first appointment that I most likely had SIRVA and that the injection seemed to have been given in my bursa. I have received PT and have continued PT home exercises. Pain continues in the morning, improves as day goes on. Lack of sleep for the past 4 months, and during sleep I have been told I cry out in pain.
Redness, firmness and tenderness left deltoid erythema is 8x9cm tender, warm to the touch. Central induration 6x3cm. Patient had PNEUMOVAX and flu shot given in left deltoid 9/12/14. She noted feeling achy the following day. Then she noted redness, firmness and tenderness left deltoid. No fever or chills. Today the erythema is measuring 8 x 9 cm, the central induration 6 x 3 cm. Tender, warm. No fever. She maintains that she had never had the PNEUMOVAX in the past. A line is drawn at the border of erythema. She is to call if the erythema advances beyond the border, or if she develops fever/chills. She can apply ice to the area. Also noted is a plaque type lesion more proximally on the arm with erythematous serpiginous border, yet the mid to inferior portion of the lesion with healing ulcerations/eschar. She states that this lesion has been shrinking. Well refer her to derm.
Information has been received from an office manager concerning a 4 year old male patient who on 05-APR-2010, was vaccinated with a dose of MMR II (Lot # 665801-1288Y) in his leg (right or left leg was unspecified). It was reported that "2 days after MMR II was given", on 07-APR-2010, the patient's leg was "triplet in size". At the time of the report the patient was recovering. The patient sought medical attention by an office visit to the physician. This is one of several reports received from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Follow up information has been received from an office manager who indicated that the patient was a male who on 05-APR-2010, was vaccinated with the second dose of MMR II into his left leg at 11:30. On 06-APR-2010, the day after the shot was given, (previously reported as 07-APR-2010) at 09:00 the patient's upper thigh was swollen, his leg got very hot and red. The patient was given prednisolone to reduce the reaction. The patient recovered on 08-APR-2010. No further information is available.
Patient stated they experienced a metallic taste in their mouth and was feeling dizzy. Patient's son felt uneasy and requested EMS  services. EMS arrived and checked vital signs, patient cleared by EMS and headed home after waiting for 30 minutes.
Inactivated polio vaccine ordered; inactivated influenza vaccine given (0.5mL).
I felt feverish for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I felt feverish for 2 days) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014-935) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced PYREXIA (I felt feverish for 2 days). On 30-Apr-2021, PYREXIA (I felt feverish for 2 days) had resolved.            Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-326837 (Patient Link).   Reporter did not allow further contact
TRIAGE CALLED due to syncopal episode 1:31pm pt got administered 1st Moderna covid vaccine and immediately passed out. RN called triage immediately after at 1:31pm and doctor arrived at seen 1:32 pm. 1:33 pm EKG done NSR, BP 110/90 HR 78 (lowest was 37 HR), temp 98.3, O2 97%, Blood sugar 104. 1:38 pm 911 called Time of EMS arrival and transport pt is awake, alert, oriented.  Of note, pt states she usually passes out during vaccinations.
sinus congestion headache, body aches, exposure, sore throat, cough, fever, chills, shortness of breath, diarrhea. starting 1/9/22
Lips swelling, itchy face, jaw pain and HA. Patient also received allergy shot 3 days prior to  vaccine at allergist office.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Shakiness-Medium, Additional Details: patient said she is very anxious about possible reaction with pfizer vaccine short and long term. she felt better before leaving. Was given electrolytes and snacks because she stated she didn't have any food before vaccination. BP and HR were within normal range
I've had about four bloody noses since I was vaccinated. Previously, I hadn't had a bloody nose since I was a child. Each bloody nose is very short - just feels like my nose is running and I go to wipe it and there is blood. It lasts just 30 seconds or so.
Approx 12 hours after administration pt developed extreme arm pain, axillary lymphadenopathy, severe fevers and chills. Lymphadenopathy spread into his ipsilateral torso and he developed a painful subareolar lump. Experienced same symptoms on the right side when administered dose 2 in the right arm (same Lot #). Also experienced extreme fatigue and dyspnea on exertion that patient says was not present prior to the vaccination, even when he was isolating with COVID. Recovered from COVID 12-14 days prior to vaccine administration. Did not receive monoclonal antibody infusion or other similar treatment. Continues to have significant fatigue, dyspnea on exertion, and subareolar masses.
This spontaneous report was received from an office manager and refers to a 5-year-old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 14-NOV-2016, the patient was vaccinated with the second improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Patient was given a bivalent dose instead of a monovalent to finish primary series. No symptoms reported. CDC recommendations were to administer monovalent dose immediately with no minimum interval. Patient declined and would like to wait the 2 months and received the monovalent vaccine at that time.
within 5-10 mins of injection to left upper arm patient began to have pain at site of injection and then pain traveling the arm to hand. Pain was constant, aching throbbing and also numbness. Took tylenol, hydrocodone, used heat. Pain worsened overnight to 10/10 but improved somewhat the following day. By this afternoon 8/10, no relief from any of above treatments.
on same day: headache a 10 hours after application                               small left arm pain next day: morning ok                        after 34 hours heavy headache, nausea, strong left arm pain two days later: morning ok 60 hours mild headache, mild left arm pain three days after: tiredness at the end of the day Fourth day: back to normal
this is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot/batch number: SDPHO EN6206), Dose: 1 via an unspecified route of administration in the left arm on 11Mar2021 at 11:00 AM (at the age of 34-years-old), as a single dose for COVID-19 Immunization. The patient was allergic to latex, curry, nickel and other alloys. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient was not receiving any concomitant medications. The patient did not receive any vaccine within 4 weeks prior to the COVID-19 vaccine. On 11Mar2021 at 21:00, the patient experienced new loss of taste and tongue numbness. The patient underwent lab test on 15Mar2021 which included polymerase chain reaction via a nasal swab and the test result was negative. The patient did not receive any treatment for the adverse events. The clinical outcome of new loss of taste and tongue numbness was recovering. No follow-up attempts are needed. No further information is expected.
She got her vaccine, everything was fine.  The very next day the arm was sore, which she was told was going to happen.  She noticed that it was on the evening of the 19th she noticed that her foot had feelings of being numb.  She waited until the next morning, text on the portal and sent them a message and asked if this was a AE to the vaccine as it was numb.  She was told that they did not think it was, and to watch it.  It has progressively gotten worse, and now it's like that her foot does not want to work.  She cannot pull her foot towards her body.  Her ankle and down the side of her leg is numb as well.  She went to her doctor today, just got done being there.  Her doctor felt that it might be the shot that might have caused the Guillaine-Barre and called her in some medicine, a steroid and referred her to a neurologist.
Pt given Influenza injection and mist this date. Was supposed to receive H1N1 injection no adverse reaction.
Moderna COVID- 19 Vaccine  Patient received her second Covid-19 vaccine (Moderna) at about 2:45 pm.  Patient and spouse waited in clinic and had been checked on to assess if there were any problems.  At approx. 3:05 she reported that she was having a local skin reaction on neck and was feeling "jittery", "like she had drank too much caffiene". Localized skin reaction to the neck.  Approx. 4x4 inch in size extending from just above breasts to middle of neck.  Marks were placed on neck to assess if reddness was extending.  Which it did not.  Patient was given 50mg of Benedryl by mouth at 3:15 pm.  Monitored patient for changes. Assessed blood pressure and O2.  3:10-152/91 pulse 94 O2 97%, 3:30- 140/90, 92, 97%; 3:35 133/84, 84, 96%.  Patient left clinic about 3:50pm.  Stated that she was feeling better but sleepy due to Benedryl.  Rash had not spread or worsened. Patient was stable and accompanied by spouse.
CHIEF COMPLAINT:   Per EMS, pt family stated that she has increased confusion and has been SOB. Per EMS they found her laying in bed with o2 sat in 70s on RA. Pt speaking in full sentences on CPAP. Denies any SOB, CP/pressure/discomfort. States CP and SOB worse on movement
Sore arm and severe pain 2 days after the second vaccine in my left shoulder and down my are - affecting my elbow, wrist and my finger were completely numb, and this has persist now for over 2 weeks and wakes me up at night.
It seemed like the second dose was higher on my right arm than the first dose. When it was given, it hurt a lot and there was a burning sensation. My right arm hurt a lot immediatetly afterward and the pain was severe for the first couple of days after the second dose. The pain decreased but was still there, mainly when lifting my right arm. The pain gets worse the higher I lift my right arm. It has been over three weeks and there is no improvement. The pain is mild and I can still move my arm, but it is very annoying.
p/vax pt had sore arm; devel sore neck, got tired; sore leg muscles; no appetite & sl stomach cramps; Case, reference number 1999009261-1, is a spontaneous report from a mother referring to her 16 year old son. No allergies, medical history, or concomitant medications. The patient had received three hepatitis B doses and the flu vaccine in the past without any problems. On 24-Mar-99, the patient received the first IM dose of LYMERIX for prevention of LYME disease. 20 seonds later, on 24-MAR-99, he had a sore arm, which lasted four days. Subsequently, he developed a sore neck, which lasted two days, got tired for 7-10 days or more. He had sore leg muscles which lasted two days or more. He had no appetite and slight stomach cramps for at least seven days. All symptoms resolved in April, 1999, within two weeks of receiving LYMERIX. The most recent information, received on 08-Feb-00, reports the condition of the patient resolved.
Pt. received one dose of the vial that expired 4/6/22-6 days prior. I made a  full report to Moderna.  No action was recommended.
Information has been received from a physician concerning a 5 year old male who was vaccinated with a 0.5ml SC dose of Varivax. On 08-MAR-2006 the patient experienced breakthrough varicella. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Patient passed out briefly after leaving the pharmacy following the immunization-- after the injection was administered, patient said she was fine.  She left pharmacy only to return after feeling light-headed.  She passed out and we were able to lay her down gently and called for management and 911. She was only out momentarily and within a few minutes said she was fine.  She also said that this had been a problem for her in the past but it had been a while since she had passed out   once the rescue squad arrived she said she was fine and refuse treatment.